FDA — authorised 8 September 1959
- Application: NDA012003
- Marketing authorisation holder: ABBVIE
- Local brand name: AKINETON
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Akineton in United States
FDA authorised Akineton on 8 September 1959
Marketing authorisations
FDA — authorised 20 April 1961
- Application: NDA012418
- Marketing authorisation holder: ABBVIE
- Local brand name: AKINETON
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Status: approved
Akineton in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Akineton approved in United States?
Yes. FDA authorised it on 8 September 1959; FDA authorised it on 20 April 1961; FDA has authorised it.
Who is the marketing authorisation holder for Akineton in United States?
ABBVIE holds the US marketing authorisation.